| Lipids Management |
1 |
1 |
| Cardiovascular Risk Management |
0 |
1 |
| Familial Hypercholesterolemia |
0 |
0.58 |
| Statins |
0 |
0.54 |
| Cardiovascular disease |
0 |
0.41 |
| Hypercholesterolemia |
0 |
0.41 |
| Food and Drug Administration (FDA) |
0 |
0.27 |
| LDL Cholesterol |
0 |
0.27 |
| Dyslipidemia |
0 |
0.14 |
| PCSK9 |
0 |
0.14 |
| Receptors |
0 |
0.14 |